Back to Search
Start Over
Oxytocin stimulates in vitro angiogenesis via a Pyk-2/Src-dependent mechanism.
- Source :
-
Experimental cell research [Exp Cell Res] 2009 Nov 01; Vol. 315 (18), pp. 3210-9. Date of Electronic Publication: 2009 Jun 27. - Publication Year :
- 2009
-
Abstract
- We previously reported that the hypothalamic hormone oxytocin (OT), best known for its uterotonic activity, also stimulates migration and invasion in human umbilical vein endothelial cells (HUVECs), thus suggesting a possible role for the peptide in the regulation of angiogenesis. We identified the Gq coupling of OT receptors (OTRs) and phospholipase C (PLC) as the main effectors of OT's action in HUVECs. Moreover, the pro-migratory effect of OT required the OTR-induced activation of the phosphatidylinositol-3-kinase (PI-3-K)/AKT/endothelial nitric oxide synthase (eNOS) pathway. To better characterize the proposed pro-angiogenic effect of OT in HUVECs, we have now utilized a three-dimensional (3-D) in vitro angiogenesis assay, and demonstrated that OT stimulates the outgrowth of capillary-like structures from HUVEC spheroids to an extent comparable to that of vascular endothelial growth factor (VEGF). This OT effect was abolished by inhibitors of PLC, PI-3-K and Src kinase. It was also found that OT phosphorylates proline-rich tyrosine kinase-2 (Pyk-2) and Src kinase in a PLC- and calcium-dependent manner. Furthermore, knockdown of Pyk-2 expression by RNA interference markedly impaired Src phosphorylation, migration and endothelial cell sprouting induced by OT. In conclusion, by using a pharmacological and genetic approach, the OT pro-angiogenic action and the cascade of intracellular signals responsible for it were defined by showing for the first time that OT, by interacting with its Gq-coupled receptor, induces HUVEC capillary outgrowth via Pyk-2 phosphorylation, which activates Src which in turn activates the PI-3-K/AKT pathway.
- Subjects :
- Cell Movement drug effects
Cell Movement physiology
Cells, Cultured
Chromones pharmacology
Endothelial Cells cytology
Endothelial Cells metabolism
Enzyme Inhibitors pharmacology
Estrenes pharmacology
Focal Adhesion Kinase 2 drug effects
Focal Adhesion Kinase 2 genetics
GTP-Binding Protein alpha Subunits, Gq-G11 drug effects
GTP-Binding Protein alpha Subunits, Gq-G11 metabolism
Humans
Morpholines pharmacology
Phosphatidylinositol 3-Kinases metabolism
Phosphodiesterase Inhibitors pharmacology
Phosphoinositide-3 Kinase Inhibitors
Phosphorylation drug effects
Phosphorylation physiology
Phosphotransferases (Alcohol Group Acceptor) antagonists & inhibitors
Phosphotransferases (Alcohol Group Acceptor) metabolism
Proto-Oncogene Proteins c-akt drug effects
Proto-Oncogene Proteins c-akt metabolism
Pyrimidines pharmacology
Pyrrolidinones pharmacology
RNA, Small Interfering metabolism
Receptors, Oxytocin drug effects
Receptors, Oxytocin metabolism
Signal Transduction drug effects
Signal Transduction physiology
Sphingosine analogs & derivatives
Sphingosine pharmacology
Type C Phospholipases antagonists & inhibitors
Umbilical Veins cytology
Umbilical Veins drug effects
Vascular Endothelial Growth Factor A pharmacology
src-Family Kinases antagonists & inhibitors
Endothelial Cells drug effects
Focal Adhesion Kinase 2 metabolism
Neovascularization, Physiologic
Oxytocin pharmacology
Type C Phospholipases metabolism
src-Family Kinases metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1090-2422
- Volume :
- 315
- Issue :
- 18
- Database :
- MEDLINE
- Journal :
- Experimental cell research
- Publication Type :
- Academic Journal
- Accession number :
- 19563802
- Full Text :
- https://doi.org/10.1016/j.yexcr.2009.06.022